<p>(<b>A</b>) Necrosis of cells treated as indicated was determined according to lactate dehydrogenase release in the supernatant. (<b>B</b>) Cell viability was determined by calcein AM staining (esterase activity analysis) of cells treated as indicated, and the apoptotic cell population (reduced esterase activity) is indicated in representative histograms. (<b>C</b>) Cells were incubated with DZNep (0.2, 1, 3, or 5 μM) alone for 40 h, and cell proliferation was determined by CellTiter 96 assay.</p
<p>(<b>A</b>) Expression of cFLIP isoforms (long and short) and methyltransferase EZH2 in different ...
<p>SW1353 and CH2879 cells were treated with DZNep (1 µM) for 72 h. A) EZH2 protein expression was a...
<p>CH2878 cells (A), SW1353 (B), or chondrocytes (C) were treated with DZNep (1 µM) for 14 days. Tre...
<p>(<b>A</b>) Cells were pre-treated with DZNep (1 μM) for 24 h followed by stimulation with TRAIL (...
<p>(<b>A</b>) Cells pre-treated with DZNep (1 μM, 24 h) were stimulated with TRAIL (20 ng/ml, 0.5–6 ...
<p>(<b>a</b>) Exponentially growing MM cells were either treated with vehicle (DMSO 0.1%) or DZNep 1...
<p>(<b>a</b>) Responsive 8226 and resistant LP1 cells were either treated with vehicle or DZNep (1 µ...
<p>Exponentially growing MM cells were either treated with vehicle (DMSO 0.1%) or DZNep 1 µM for 72 ...
<p>Cells were treated with DZNep (1 µM) for 7 days (A and C) or 5 days (B). A) At day 7, cells were ...
<p><b>A</b>) DZNep exposure at different concentrations (0.5 µM and 1 µM) significantly reduced let-...
<p>JJN3 DZNep-sensitive cells and LP1 DZNep-resistant cells were either treated with vehicle or DZNe...
<p>(<b>A</b>) Analysis of caspase-8, caspase-3, and PARP processing of cells pre-treated with DZNep ...
Enhancer of zeste homolog 2 (EZH2) tri-methylates histone 3 at position lysine 27 (H3K27me3). Overex...
<p>Proliferation study in, <b>A</b>) KG1a cells overexpressing let-7b, <b>B</b>) primary marrow cell...
<p>(<b>a</b>) Stromal HS-5 cells were seeded in 96-well plates at the density of 10<sup>4</sup> cell...
<p>(<b>A</b>) Expression of cFLIP isoforms (long and short) and methyltransferase EZH2 in different ...
<p>SW1353 and CH2879 cells were treated with DZNep (1 µM) for 72 h. A) EZH2 protein expression was a...
<p>CH2878 cells (A), SW1353 (B), or chondrocytes (C) were treated with DZNep (1 µM) for 14 days. Tre...
<p>(<b>A</b>) Cells were pre-treated with DZNep (1 μM) for 24 h followed by stimulation with TRAIL (...
<p>(<b>A</b>) Cells pre-treated with DZNep (1 μM, 24 h) were stimulated with TRAIL (20 ng/ml, 0.5–6 ...
<p>(<b>a</b>) Exponentially growing MM cells were either treated with vehicle (DMSO 0.1%) or DZNep 1...
<p>(<b>a</b>) Responsive 8226 and resistant LP1 cells were either treated with vehicle or DZNep (1 µ...
<p>Exponentially growing MM cells were either treated with vehicle (DMSO 0.1%) or DZNep 1 µM for 72 ...
<p>Cells were treated with DZNep (1 µM) for 7 days (A and C) or 5 days (B). A) At day 7, cells were ...
<p><b>A</b>) DZNep exposure at different concentrations (0.5 µM and 1 µM) significantly reduced let-...
<p>JJN3 DZNep-sensitive cells and LP1 DZNep-resistant cells were either treated with vehicle or DZNe...
<p>(<b>A</b>) Analysis of caspase-8, caspase-3, and PARP processing of cells pre-treated with DZNep ...
Enhancer of zeste homolog 2 (EZH2) tri-methylates histone 3 at position lysine 27 (H3K27me3). Overex...
<p>Proliferation study in, <b>A</b>) KG1a cells overexpressing let-7b, <b>B</b>) primary marrow cell...
<p>(<b>a</b>) Stromal HS-5 cells were seeded in 96-well plates at the density of 10<sup>4</sup> cell...
<p>(<b>A</b>) Expression of cFLIP isoforms (long and short) and methyltransferase EZH2 in different ...
<p>SW1353 and CH2879 cells were treated with DZNep (1 µM) for 72 h. A) EZH2 protein expression was a...
<p>CH2878 cells (A), SW1353 (B), or chondrocytes (C) were treated with DZNep (1 µM) for 14 days. Tre...